Bloocell® manufactures equipment and automation systems at high standards to meet the quality requirements of the aerospace and medical / pharmaceutical industries. The biotechnology department established within our organization conducts research on artificial tissues and organs. We serve the humanity with our products developed as a result of successful in vitro and in vivo studies. We conduct and conclude valuable studies thanks to the strengths of our structure consisting of different branches of science. Our organization focuses on long-term academic work to provide new-generation and advanced health services. The Bloocell® technology offers innovations for the medical applications of the future. All of our products are developed using the latest technology. We comply with international quality standards with the goal of providing safer and more effective clinical solutions. Bloocell ® products are manufactured using a polymeric biomaterial called polycaprolactone (PCL), which has been approved by the U.S. Food and Drug Administration (FDA) for various applications. PCL can be biologically resorbed, decays slowly and has a mechanical strength close to trabecular bone. In the current climate of increased life expectancy with an increase in bone-related injuries, a paradigm shift is taking place in applications such as orthopedic, dental, plastic and reconstructive surgery from standard bone grafting to tissue engineering /tissue regeneration recovery. The engineering team of Bloocell® conducts research to design a technological platform for the production of scaffolds that will enable 3-dimensional (3D) bone tissue regeneration. Our products are manufactured in-house using the 3D printing technology, which allows the customization of precise shapes and geometries. This approach has critical importance for products to fully adapt to anatomical structure.....
